688526.SH
科前生物
SSE · Healthcare · Biotechnology · CN
CNY 12.97
−0.92%Margins
Gross margin
66.5%
EBITDA margin
63.9%
EBIT margin
48.0%
Net margin
41.8%
FCF margin
27.9%
9.0%
Return on equity
8.1%
Return on assets
10.4%
Return on invested capital
0.19x
Asset turnover
CNY 379.0M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026